NCT01982084

Brief Summary

Group B Streptococcus (GBS) is the commonest cause of severe infection and meningitis in babies under 3 months in the United Kingdom (UK). About one in ten babies with GBS infection die and half of babies with GBS meningitis are left with long term problems with their development. Vaccinating pregnant women against GBS in order to protect their newborn babies is a promising area of research.However, many women are reluctant to accept vaccination during pregnancy for fear it will harm their unborn child and there is often a lack of understanding of both the vaccine and the condition it aims to prevent. Nevertheless, the recent positive experience of immunisation against pertussis in the United Kingdom, suggest that antenatal immunisation can be acceptable. Previous research has shown that advice from maternity healthcare professionals regarding vaccination is highly valued by pregnant women so it is also important to explore the attitudes and opinions of this group. The objective of this study is to assess the knowledge and attitudes of pregnant women and maternity healthcare professionals in England and Scotland regarding GBS disease and the acceptability of a potential vaccine. There are two parts to this study. The first part will invite pregnant women, maternity healthcare professionals and parents who have had a child affected by GBS disease to take part in either a focus group or an individual interview. This will allow for an in-depth exploration of the participants thoughts and opinions about GBS and vaccination in pregnancy. This part of the study will take place at the Oxford site only. The results will guide the development of a self completed, paper questionnaire which will be distributed to a wider range of pregnant women and maternity healthcare professionals across four different study sites. This study has been funded by Meningitis UK. Additional collaborators to those listed include the charity Group B Strep Support.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
758

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 13, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2014

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

2 months

First QC Date

October 10, 2013

Last Update Submit

April 3, 2018

Conditions

Keywords

Group B streptococcusImmunisationPregnancyAttitudes

Outcome Measures

Primary Outcomes (1)

  • The attitudes of pregnant women and maternity healthcare professionals towards vaccination against Group B streptococcus in pregnancy

    The attitude of pregnant women and maternity healthcare professionals will be measured using their responses to questions asked during interviews or focus groups

    Single timepoint at interview or focus group lasting on average 1-2 hours

Other Outcomes (1)

  • Attitudes of pregnant women to participating in a clinical trial of a GBS vaccine

    Single time point at interview or focus group lasting on average 1-2 hours

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women aged 18 years and over of any gestation receiving antenatal care in the Oxford area (part one and two) or within Imperial college and St Georges's NHS trusts in London and Edinburgh Royal infirmary (part two). Maternity healthcare professionals (midwives and doctors)working in the above areas. Parents who have had a child with Group B streptococcal disease (part one only).

You may qualify if:

  • Pregnant women aged 18 years and above who have not previously had a child with GBS disease and are willing and able to give written, informed consent and are able to read and speak English. OR
  • Obstetricians (including consultants and trainees) or midwives working at one of the study site who are willing and able to give written, informed consent OR
  • Parents (mothers or fathers) of children who have had GBS disease (early or late onset), potentially including parents of children who have died from GBS disease who are willing and able to given written, informed consent Able to read and speak English

You may not qualify if:

  • Volunteer is part of the study team at any of the study sites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Edinburgh Royal Infirmary

Edinburgh, United Kingdom

Location

Imperial College London

London, United Kingdom

Location

St Georges University of London

London, United Kingdom

Location

Oxford Vaccine Group, University of Oxford

Oxford, OX3 7LE, United Kingdom

Location

Related Publications (2)

  • McQuaid F, Pask S, Locock L, Davis E, Stevens Z, Plumb J, Snape MD. Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals. Vaccine. 2016 Jul 25;34(34):4056-61. doi: 10.1016/j.vaccine.2016.06.024. Epub 2016 Jun 16.

  • McQuaid F, Jones C, Stevens Z, Meddaugh G, O'Sullivan C, Donaldson B, Hughes R, Ford C, Finn A, Faust SN, Gbesemete D, Bedford H, Hughes S, Varghese AS, Heath PT, Snape MD. Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018 Mar;97(3):330-340. doi: 10.1111/aogs.13288. Epub 2018 Jan 19.

MeSH Terms

Conditions

Behavior

Study Officials

  • Matthew Snape, MBBS FRCPCH

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2013

First Posted

November 13, 2013

Study Start

January 1, 2014

Primary Completion

March 1, 2014

Study Completion

March 29, 2014

Last Updated

April 5, 2018

Record last verified: 2018-04

Locations